Nemaura Medical (NMRD) Short Interest Ratio & Short Volume

Short interest is the volume of Nemaura Medical shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 51,100 shares of NMRD short. 0.34% of Nemaura Medical's shares are currently sold short. Learn More on Nemaura Medical's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.34% of Nemaura Medical's floating shares are currently sold short.

Nemaura Medical saw a decline in short interest in December. As of December 31st, there was short interest totaling 51,100 shares, a decline of 2.9% from the previous total of 52,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Nemaura Medical currently has issued a total of 40,350,000 shares. Some of Nemaura Medical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nemaura Medical currently has a public float of 14,950,000 shares.

0.34% of Nemaura Medical's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Nemaura Medical: Tenon Medical, Inc. (1.82%), Dynatronics Co. (0.58%), Quoin Pharmaceuticals, Ltd. (0.41%), ProSomnus, Inc. (1.18%), INVO Bioscience, Inc. (0.65%), ReShape Lifesciences Inc. (2.34%), Minerva Surgical, Inc. (92.12%), Aethlon Medical, Inc. (1.31%), Bluejay Diagnostics, Inc. (0.02%), Assure Holdings Corp. (2.04%),

As of the most recent reporting period, the following stocks had the largest short interest positions: General Motors ($4.15 billion), T-Mobile US, Inc. ($3.92 billion), TC Energy Co. ($3.66 billion), Charter Communications, Inc. ($3.35 billion), Coinbase Global, Inc. ($3.32 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.80 billion), Rivian Automotive, Inc. ($2.44 billion), Moderna, Inc. ($2.41 billion), and United Rentals, Inc. ($2.23 billion). View all of the most shorted stocks.

Short selling NMRD is an investing strategy that aims to generate trading profit from Nemaura Medical as its price is falling. NMRD shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nemaura Medical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NMRD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NMRD, twice per month. The most recent reporting period available is December, 31 2023.